Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 1
2016 1
2019 1
2020 2
2021 2
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Among authors: ribeiro l. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.
Organization and implementation of a cardio-oncology program.
Fiuza M, Ribeiro L, Magalhães A, Sousa AR, Nobre Menezes M, Jorge M, Costa L, Pinto FJ. Fiuza M, et al. Among authors: ribeiro l. Rev Port Cardiol. 2016 Sep;35(9):485-94. doi: 10.1016/j.repc.2016.04.006. Epub 2016 Aug 5. Rev Port Cardiol. 2016. PMID: 27503589 Free article. Review. English, Portuguese.
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities.
Esperança-Martins M, Melo-Alvim C, Dâmaso S, Lopes-Brás R, Peniche T, Nogueira-Costa G, Abreu C, Luna Pais H, de Sousa RT, Torres S, Gallego-Paez LM, Martins M, Ribeiro L, Costa L. Esperança-Martins M, et al. Among authors: ribeiro l. Cancers (Basel). 2023 Aug 2;15(15):3933. doi: 10.3390/cancers15153933. Cancers (Basel). 2023. PMID: 37568749 Free PMC article. Review.
HER family in cancer progression: From discovery to 2020 and beyond.
Kumar R, George B, Campbell MR, Verma N, Paul AM, Melo-Alvim C, Ribeiro L, Pillai MR, da Costa LM, Moasser MM. Kumar R, et al. Among authors: ribeiro l. Adv Cancer Res. 2020;147:109-160. doi: 10.1016/bs.acr.2020.04.001. Epub 2020 Jun 5. Adv Cancer Res. 2020. PMID: 32593399 Review.
Prognostic Factors after Liver Resection for Colorectal Liver Metastasis.
Matias M, Casa-Nova M, Faria M, Pires R, Tato-Costa J, Ribeiro L, Costa L. Matias M, et al. Among authors: ribeiro l. Acta Med Port. 2015 May-Jun;28(3):357-69. doi: 10.20344/amp.4816. Epub 2015 Jun 30. Acta Med Port. 2015. PMID: 26421789 Free article. Review.
Prognostic factors for patients treated with abiraterone.
Alvim CM, Mansinho A, Paiva RS, Brás R, Semedo PM, Lobo-Martins S, da Ponte CB, Macedo D, Ribeiro L, Dos Reis JP, Fernandes I, Costa L. Alvim CM, et al. Among authors: ribeiro l. Future Sci OA. 2019 Dec 12;6(2):FSO436. doi: 10.2144/fsoa-2019-0079. Future Sci OA. 2019. PMID: 32025327 Free PMC article.
15 results